[Recent advances in the treatment of hepatitis C in 2016].
作者信息
Luo B F, Wei L
机构信息
Peking University People's Hospital, Peking University Hepatology Institute, Beijing 100044, China.
出版信息
Zhonghua Gan Zang Bing Za Zhi. 2017 Mar 20;25(3):175-180. doi: 10.3760/cma.j.issn.1007-3418.2017.03.004.
Abstract
It has been rapidly developed in treatment of chronic hepatitis C from the past few years. Here we summarize the progress in chronic hepatitis C treatment in 2016. We introduce the pan-genotypic regimens with short-duration, the efficacy of DAA regimens in difficult-to-treat population, the influence on hepatocellular carcinoma, decompensation of liver cirrhosis, liver fibrosis and liver transplantation, the safety of DAA regimens in special population, information from real-world studies and data from China.
摘要
Zotero 插件